Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates

Yasinska, Inna M.; Ceccone, Giacomo; Ojea-Jimenez, Isaac; Ponti, Jessica; Hussain, Rohanah; Siligardi, Giuliano; Berger, Steffen M.; Fasler-Kan, Elizaveta; Bardelli, Marco; Varani, Luca; Fiedler, Walter; Wellbrock, Jasmin; Raap, Ulrike; Gibbs, Bernhard F.; Calzolai, Luigi; Sumbayev, Vadim V. (2018). Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates. Nanoscale, 10(13), pp. 5827-5833. Royal Society of Chemistry 10.1039/c7nr09436a

[img]
Preview
Text
c7nr09436a.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (2MB) | Preview

In this study we used 5 nm gold nanoparticles as delivery platforms to target cancer cells expressing the immune receptor Tim-3 using single chain antibodies. Gold surfaces were also covered with the cytotoxic drug rapamycin which was immobilised using a glutathione linker. These nanoconjugates allowed highly specific and efficient delivery of cytotoxic rapamycin into human malignant blood cells.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Unit Childrens Hospital > Research Group Pediatric Surgery
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Surgery

UniBE Contributor:

Berger, Steffen Michael, Fasler-Kan, Elizaveta

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2040-3364

Publisher:

Royal Society of Chemistry

Language:

English

Submitter:

Christoph Steffen

Date Deposited:

26 Nov 2018 11:00

Last Modified:

05 Dec 2022 15:17

Publisher DOI:

10.1039/c7nr09436a

PubMed ID:

29538473

BORIS DOI:

10.7892/boris.119583

URI:

https://boris.unibe.ch/id/eprint/119583

Actions (login required)

Edit item Edit item
Provide Feedback